Mangiferonic Acid

Mangiferonic Acid

SCHEMBL30415919

C/C(=C\CC[C@@H](C)[C@H]1CC[C@@]2(C)[C@@H]3CC[C@H]4C(C)(C)C(=O)CC[C@@]45C[C@@]35CC[C@]12C)C(=O)O

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACLY P53396 2/20 0.70
▸ ACACA Q13085 2/20 0.70
▸ MAPK1 P28482 1/20 0.63
▸ HSD11B1 P28845 2/20 0.62
▸ MEN1 O00255 1/20 0.60
▸ PLA2G1B P04054 1/20 0.60
▸ MAPT P10636 1/20 0.60
▸ DNMT1 P26358 1/20 0.60
▸ BLM P54132 1/20 0.60
▸ KMT2A Q03164 1/20 0.60
▸ ATG4B Q9Y4P1 1/20 0.60
▸ ESR2 Q92731 2/20 0.53
▸ PTPN11 Q06124 1/20 0.50
▸ HMGCR P04035 2/20 0.49
▸ ESR1 P03372 1/20 0.49
▸ FNTA P49354 1/20 0.48
▸ FNTB P49356 1/20 0.48
▸ PTGS1 P23219 1/20 0.46
▸ PTGS2 P35354 1/20 0.46
▸ ACHE P22303 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mangiferonic Acid SCHEMBL29873759 1.00 ACLY (0.70) ACLYACACAMAPK1HSD11B1MEN1
Cycloartenone SCHEMBL29504219 0.90 HSD11B1 (0.61) ACLYACACAMAPK1HSD11B1MEN1
SCHEMBL29934719 0.84 PTPN11 (0.71) ACLYACACAMAPK1HSD11B1MEN1
Isomangiferolic Acid SCHEMBL30515225 0.83 ACLY (1.00) ACLYACACAMAPK1HSD11B1MEN1
Mangiferolic Acid SCHEMBL17057008 0.83 ACLY (1.00) ACLYACACAMAPK1HSD11B1MEN1
Mangiferolic Acid SCHEMBL31097460 0.83 ACLY (1.00) ACLYACACAMAPK1HSD11B1MEN1
SCHEMBL5824245 0.82 HSD11B1 (0.69) ACLYACACAMAPK1HSD11B1MEN1
SCHEMBL29934767 0.80 HSD11B1 (0.77) ACLYACACAMAPK1HSD11B1MEN1
Vaticinone SCHEMBL29670808 0.80 HSD11B1 (0.60) ACLYACACAMAPK1HSD11B1MEN1
SCHEMBL31237297 0.80 HSD11B1 (0.82) ACLYACACAMAPK1HSD11B1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4731172-A2 COSMETIC COMPOSITION COMPRISING AT LEAST ONE NATURAL RESIN AND A CRYSTALLIZABLE FATTY SUBSTANCE L'OREAL (FR) 2026-04-29 — — EP disclosed
US-20250213441-A1 Cosmetic Composition Comprising a Natural Resin L'OREAL (FR) 2025-07-03 — — US disclosed
EP-4551184-A1 LIQUID EMULSION COMPRISING ETHYLCELLULOSE, A NATURAL RESIN, A LIQUID FATTY ALCOHOL, A SOLID ESTER AND/OR A POLAR HYDROCARBON-BASED OIL AND PROCESS USING SAME L'OREAL (FR) 2025-05-14 — — EP disclosed
EP-4551300-A1 COSMETIC COMPOSITION COMPRISING A NATURAL RESIN L'OREAL (FR) 2025-05-14 — — EP disclosed
US-20250064716-A1 COSMETIC COMPOSITION COMPRISING A NATURAL RESIN L'OREAL (FR) 2025-02-27 — — US disclosed
US-20250064711-A1 COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE COPOLYMER BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN AND A NATURAL RESIN L'OREAL (FR) 2025-02-27 — — US disclosed
WO-2024261287-A2 COSMETIC COMPOSITION COMPRISING AT LEAST ONE NATURAL RESIN AND A CRYSTALLIZABLE FATTY SUBSTANCE L'OREAL (FR) 2024-12-26 — — WO disclosed
EP-4452200-A1 COSMETIC COMPOSITION COMPRISING A NATURAL RESIN L'OREAL (FR) 2024-10-30 — — EP disclosed
EP-4452418-A1 COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE COPOLYMER BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN AND A NATURAL RESIN L'OREAL (FR) 2024-10-30 — — EP disclosed
WO-2024008772-A1 COSMETIC COMPOSITION COMPRISING A NATURAL RESIN L'OREAL (FR) 2024-01-11 — — WO disclosed
WO-2024008771-A1 COSMETIC COMPOSITION COMPRISING A NATURAL RESIN L'OREAL (FR) 2024-01-11 — — WO disclosed
WO-2024008769-A1 COSMETIC COMPOSITION COMPRISING A NATURAL RESIN L'OREAL (FR) 2024-01-11 — — WO disclosed
WO-2024008725-A1 LIQUID EMULSION COMPRISING ETHYLCELLULOSE, A NATURAL RESIN, A LIQUID FATTY ALCOHOL, A SOLID ESTER AND/OR A POLAR HYDROCARBON-BASED OIL AND PROCESS USING SAME L'OREAL (FR) 2024-01-11 — — WO disclosed
WO-2023118430-A1 COSMETIC COMPOSITION COMPRISING A NATURAL RESIN L'OREAL (FR) 2023-06-29 — — WO disclosed
WO-2023118529-A1 COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE COPOLYMER BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN AND A NATURAL RESIN L'OREAL (FR) 2023-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250213441-A1 Cosmetic Composition Comprising a Natural Resin KRT18, CUTA, EPCAM ACLY 575/4885ACACA 1413/4885MAPK1 4466/4885
US-20250064711-A1 COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE COPOLYMER BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN AND A NATURAL RESIN HCAR3, RARA, HCAR1 ACLY 1492/4885ACACA 955/4885MAPK1 3025/4885
US-20250064716-A1 COSMETIC COMPOSITION COMPRISING A NATURAL RESIN KRT18, CUTA, RARA ACLY 844/4885ACACA 936/4885MAPK1 4084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback